These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28854950)

  • 1. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
    Lämmer C; Weimann E
    Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.
    Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
    Growth Horm IGF Res; 2014 Feb; 24(1):16-21. PubMed ID: 24360789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study.
    Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):89-96. PubMed ID: 34792304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature pubarche in Prader-Willi syndrome: Risk factors and consequences.
    Griffing E; Halpin K; Lee BR; Paprocki E
    Clin Endocrinol (Oxf); 2024 Aug; 101(2):162-169. PubMed ID: 38935853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
    Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity: Associations with weight, BMI-z, and HOMA-IR.
    Orsso CE; Butler AA; Muehlbauer MJ; Cui HN; Rubin DA; Pakseresht M; Butler MG; Prado CM; Freemark M; Haqq AM
    Pediatr Obes; 2019 May; 14(5):e12493. PubMed ID: 30589518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
    Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review.
    van Abswoude DH; Pellikaan K; Nguyen N; Rosenberg AGW; Davidse K; Hoekstra FME; Rood IM; Poitou C; Grugni G; Høybye C; Markovic TP; Caixàs A; Crinò A; van den Berg SAA; van der Lely AJ; de Graaff LCG
    Front Endocrinol (Lausanne); 2023; 14():1168648. PubMed ID: 37547314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
    Crinò A; Grugni G
    Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25OH vitamin D levels in pediatric patients affected by Prader-Willi syndrome.
    Fintini D; Pedicelli S; Bocchini S; Bizzarri C; Grugni G; Cappa M; Crinò A
    J Endocrinol Invest; 2018 Jun; 41(6):739-742. PubMed ID: 29101669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.
    Panfili FM; Convertino A; Grugni G; Mazzitelli L; Bocchini S; Crinò A; Campana G; Cappa M; Delvecchio M; Faienza MF; Licenziati MR; Mariani M; Osimani S; Pajno R; Patti G; Rutigliano I; Sacco M; Scarano E; Fintini D;
    J Endocrinol Invest; 2023 Jul; 46(7):1397-1406. PubMed ID: 36708456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.
    Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F
    J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.
    Mai S; Fintini D; Mele C; Convertino A; Bocchini S; Grugni G; Aimaretti G; Vietti R; Scacchi M; Crinò A; Marzullo P
    Front Endocrinol (Lausanne); 2022; 13():918467. PubMed ID: 35774143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.